The present study aimed to investigate the potential of piericidin A to trigger a tauopathy in vivo in wild type mice or to modify the course of a genetically caused tauopathy in transgenic mice overexpressing human P301S mutant tau [26]. This evidence concerns the gene MAPT and tauopathy.